droxidopa has been researched along with Amyloid Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, A; Katsube, J; Narabayashi, H; Suzuki, T; Tanaka, C | 1 |
| Ando, M; Ando, Y; Araki, S | 1 |
| Boomsma, F; Carvalho, MJ; Costa, O; de Freitas, AF; Freitas, J; Man in 't Veld, AJ; van den Meiracker, AH | 1 |
1 review(s) available for droxidopa and Amyloid Neuropathies
| Article | Year |
|---|---|
[Development of L-threo-DOPS, a norepinephrine precursor amino acid].
Topics: Amyloid Neuropathies; Animals; Clinical Trials as Topic; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Norepinephrine; Parkinson Disease; Technology, Pharmaceutical | 1994 |
2 other study(ies) available for droxidopa and Amyloid Neuropathies
| Article | Year |
|---|---|
[Transthyretin and familial amyloid polyneuropathies].
Topics: Amyloid Neuropathies; Animals; DNA; Droxidopa; Genetic Variation; Humans; Mice; Mice, Transgenic; Polymerase Chain Reaction; Prealbumin; Serologic Tests | 1993 |
Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
Topics: Adult; Amyloid Neuropathies; Dose-Response Relationship, Drug; Droxidopa; Female; Humans; Hypotension, Orthostatic; Male; Norepinephrine | 1997 |